Ochsner Health, a leading nonprofit healthcare provider in the Gulf South, has been selected by the Global Parkinson鈥檚 Genetics Program (GP2) as one of six new study sites for the Black and African American Connections to Parkinson鈥檚 Disease study.
In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive Planetary Health", scientists from the University of Vienna, in collaboration with the University of Southampton, Aalborg University and Boston University, have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The study, published in Nature Microbiology, provides new insights into the often-overlooked impact of human-targeted drugs on the microbial communities that play a critical role in human health.
Algorithms that can detect subtle changes in a person鈥檚 voice are emerging as a potential new diagnostic tool for Parkinson鈥檚 disease, according to researchers from Iraq and Australia.
Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological diseases 鈥� epilepsy, multiple sclerosis (MS), peripheral neuropathy, Alzheimer鈥檚 disease and Parkinson鈥檚 disease. This is according to research published online in Neurology庐, the medical journal of the American Academy of Neurology.
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer鈥檚, and Parkinson鈥檚 disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology庐, the medical journal of the American Academy of Neurology.
New research by Rutgers Health researchers highlights a complex relationship between bacteria in the digestive tract and brain health.
The Speech Accessibility Project is now recruiting Canadian adults with Parkinson鈥檚 disease, cerebral palsy, amyotrophic lateral sclerosis, Down syndrome and those who have had a stroke.
McMaster University researchers have discovered a previously unknown cell-protecting function of a protein, which could open new avenues for treating age-related diseases and lead to healthier aging overall.
Biochemist David Baker 鈥� just announced as a recipient of the Nobel Prize for Chemistry 鈥� turned to the High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory for information he couldn鈥檛 get anywhere else. HFIR is the strongest reactor-based neutron source in the United States.
Participants from the Cedars-Sinai Accelerator鈥檚 10th class are set to showcase their leading-edge healthcare solutions during Demo Day at HLTH 2024 on Tuesday, Oct. 22, from 2:30 p.m. to 4 p.m. at The Venetian Expo Center in Las Vegas, Nevada.
At a glance: Study in mice reveals rapid release of dopamine is not needed for initiating movement but is important for activities related to reward-seeking and motivation. The findings help explain why the widely used Parkinson鈥檚 drug levodopa improves movement-related symptoms but often fails to ameliorate some cognitive ones. The work may inform the development of new therapies that restore both slow and fast dopamine action to treat multiple symptoms.
Lewy body dementia鈥�(LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can include hallucinations, movement disorders, cognitive issues, sleep problems and depression.
禺乇賮 兀噩爻丕賲 賱賷賵賷 賴賵 賲乇囟 鬲賳賰爻賷 毓氐亘賷 賲鬲賮丕賯賲 賷卮鬲乇賰 賮賷 亘毓囟 爻賲丕鬲賴 賲毓 丿丕亍 亘丕乇賰賷賳爻賵賳 賵 丿丕亍 丕賱夭賴丕賷賲乇貙 賵賱賰賳賴 賯丿 賷賰賵賳 兀賰孬乇 氐毓賵亘丞 賮賷 丕賱鬲卮禺賷氐. 賷賲賰賳 兀賳 鬲卮賲賱 丕賱兀毓乇丕囟 丕賱賴賱賵爻丕鬲 賵丕囟胤乇丕亘丕鬲 丕賱丨乇賰丞 賵賲卮丕賰賱 賮賷 丕賱廿丿乇丕賰 賵丕囟胤乇丕亘丕鬲 丕賱賳賵賲 賵丕賱丕賰鬲卅丕亘.
A dem锚ncia por corpos de Lewy鈥�(DCL) 茅 uma doen莽a neurodegenerativa progressiva que compartilha caracter铆sticas tanto da doen莽a de Parkinson quanto da doen莽a de Alzheimer, mas que pode ser mais dif铆cil de ser diagnosticada. Os sintomas podem incluir alucina莽玫es, dist煤rbios do movimento, problemas cognitivos, problemas de sono e depress茫o.
La demencia con cuerpos de Lewy (DCL) es una enfermedad neurodegenerativa progresiva que comparte caracter铆sticas tanto de la enfermedad de Parkinson cuanto de la enfermedad de Alzheimer, pero que puede ser m谩s dif铆cil de diagnosticar. Los s铆ntomas pueden incluir alucinaciones, trastornos del movimiento, problemas cognitivos, problemas para dormir y depresi贸n.
A research team from the University of California, Irvine is the first to reveal that a molecule in the brain 鈥� ophthalmic acid 鈥� unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson鈥檚 and other movement diseases.
Binghamton University, State University of New York Psychology Professor Christopher R. Bishop is part of a collaborative research team that recently received a four-year grant from The Department of Defense to investigate the underlying cause of neuropsychiatric symptoms in Parkinson鈥檚 disease.
Announcement of contents of the October 2024 issue of Neurosurgical Focus: Video
Listening to people with Parkinson鈥檚 disease made an automatic speech recognizer 30% more accurate, according to initial findings from the Speech Accessibility Project. Speech recordings used in the study are freely available to organizations looking to improve their voice recognition devices.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
